Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid CancerAlan L. Ho, James A. Fagin, Ravinder K. Grewal et al.|New England Journal of Medicine|2013Cited by 825
Cancer therapy shapes the fitness landscape of clonal hematopoiesisKelly L. Bolton, Dean F. Bajorin, Sonya Li et al.|Nature Genetics|2020Cited by 739
High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.James A. Fagin, H. Phillip Koeffler|Journal of Clinical Investigation|1993Cited by 653
Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institutionMabel Ryder, James A. Fagin|Endocrine Related Cancer|2014Cited by 439
Alternative transcription initiation leads to expression of a novel ALK isoform in cancerThomas Wiesner, Ping Chi, William Lee et al.|Nature|2015Cited by 251